Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam 1500 mg granules vs Keppra tablets bioequivalence
NCT07393022Phase 1Completed
- Sponsor
- Desitin Arzneimittel
- Start
- Dec 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levetiracetam in epilepsy (2 arms), sponsored by Desitin Arzneimittel. Primary endpoints: Bioequivalence between Levetiracetam Desitin 1500 mg coated granules and Keppra at 2 weeks and Area Under the Curve at 1 week. Started Dec 2025; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07393022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07393022.